ClinVar Miner

Submissions for variant NM_001376.5(DYNC1H1):c.10051A>T (p.Ile3351Phe)

dbSNP: rs1567018763
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV002318188 SCV000851433 likely pathogenic Inborn genetic diseases 2017-07-05 criteria provided, single submitter clinical testing The p.I3351F variant (also known as c.10051A>T), located in coding exon 52 of the DYNC1H1 gene, results from an A to T substitution at nucleotide position 10051. The isoleucine at codon 3351 is replaced by phenylalanine, an amino acid with highly similar properties. This variant has been determined to be the result of a de novo mutation or germline mosaicism in one family with an isolated case of DYNC1H1-related neurological disorder. This alteration is located in the microtubule-binding stalk of dynein motor domain and is indicated to be structurally disruptive (Ambry internal data; Mocz G et al. Structure, 2001 Feb;9:93-103; Kon T et al. Nature, 2012 Mar;484:345-50; Schmidt H et al. Nature, 2015 Feb;518:435-8; Bhabha G et al. Cell, 2014 Nov;159:857-68). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.